Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
In the Swiss HIV Cohort Study, 61 of 222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after 2 years on tenofovir, of whom 77% were suppressed thereafter. Self-reported adherence to therapy and HBV viral load at tenofovir initiation were predictors of persistent replication.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 76(2023), 4 vom: 18. Feb., Seite 730-733 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hofmann, Eveline [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
99YXE507IL |
|---|
| Anmerkungen: |
Date Completed 24.02.2023 Date Revised 18.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciac823 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347575390 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347575390 | ||
| 003 | DE-627 | ||
| 005 | 20231226034142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciac823 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1158.xml |
| 035 | |a (DE-627)NLM347575390 | ||
| 035 | |a (NLM)36242550 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hofmann, Eveline |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.02.2023 | ||
| 500 | |a Date Revised 18.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a In the Swiss HIV Cohort Study, 61 of 222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after 2 years on tenofovir, of whom 77% were suppressed thereafter. Self-reported adherence to therapy and HBV viral load at tenofovir initiation were predictors of persistent replication | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a coinfection | |
| 650 | 4 | |a hepatitis B virus | |
| 650 | 4 | |a human immunodeficiency virus | |
| 650 | 4 | |a tenofovir | |
| 650 | 4 | |a viral replication | |
| 650 | 7 | |a Tenofovir |2 NLM | |
| 650 | 7 | |a 99YXE507IL |2 NLM | |
| 650 | 7 | |a DNA, Viral |2 NLM | |
| 700 | 1 | |a Surial, Bernard |e verfasserin |4 aut | |
| 700 | 1 | |a Boillat-Blanco, Noémie |e verfasserin |4 aut | |
| 700 | 1 | |a Günthard, Huldrych F |e verfasserin |4 aut | |
| 700 | 1 | |a Stöckle, Marcel |e verfasserin |4 aut | |
| 700 | 1 | |a Bernasconi, Enos |e verfasserin |4 aut | |
| 700 | 1 | |a Schmid, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Calmy, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Suter-Riniker, Franziska |e verfasserin |4 aut | |
| 700 | 1 | |a Rauch, Andri |e verfasserin |4 aut | |
| 700 | 1 | |a Wandeler, Gilles |e verfasserin |4 aut | |
| 700 | 1 | |a Béguelin, Charles |e verfasserin |4 aut | |
| 700 | 0 | |a Swiss HIV Cohort Study |e verfasserin |4 aut | |
| 700 | 1 | |a Abela, I |e investigator |4 oth | |
| 700 | 1 | |a Aebi-Popp, K |e investigator |4 oth | |
| 700 | 1 | |a Anagnostopoulos, A |e investigator |4 oth | |
| 700 | 1 | |a Battegay, M |e investigator |4 oth | |
| 700 | 1 | |a Bernasconi, E |e investigator |4 oth | |
| 700 | 1 | |a Braun, D L |e investigator |4 oth | |
| 700 | 1 | |a Bucher, H C |e investigator |4 oth | |
| 700 | 1 | |a Calmy, A |e investigator |4 oth | |
| 700 | 1 | |a Cavassini, M |e investigator |4 oth | |
| 700 | 1 | |a Ciuffi, A |e investigator |4 oth | |
| 700 | 1 | |a Dollenmaier, G |e investigator |4 oth | |
| 700 | 1 | |a Egger, M |e investigator |4 oth | |
| 700 | 1 | |a Elzi, L |e investigator |4 oth | |
| 700 | 1 | |a Fehr, J |e investigator |4 oth | |
| 700 | 1 | |a Fellay, J |e investigator |4 oth | |
| 700 | 1 | |a Furrer, H |e investigator |4 oth | |
| 700 | 1 | |a Fux, C A |e investigator |4 oth | |
| 700 | 1 | |a Günthard, H F |e investigator |4 oth | |
| 700 | 1 | |a Hachfeld, A |e investigator |4 oth | |
| 700 | 1 | |a Haerry, D |e investigator |4 oth | |
| 700 | 1 | |a Hasse, B |e investigator |4 oth | |
| 700 | 1 | |a Hirsch, H H |e investigator |4 oth | |
| 700 | 1 | |a Hoffmann, M |e investigator |4 oth | |
| 700 | 1 | |a Hösli, I |e investigator |4 oth | |
| 700 | 1 | |a Huber, M |e investigator |4 oth | |
| 700 | 1 | |a Kahlert, C R |e investigator |4 oth | |
| 700 | 1 | |a Kaiser, L |e investigator |4 oth | |
| 700 | 1 | |a Keiser, O |e investigator |4 oth | |
| 700 | 1 | |a Klimkait, T |e investigator |4 oth | |
| 700 | 1 | |a Kouyos, R D |e investigator |4 oth | |
| 700 | 1 | |a Kovari, H |e investigator |4 oth | |
| 700 | 1 | |a Kusejko, K |e investigator |4 oth | |
| 700 | 1 | |a Martinetti, G |e investigator |4 oth | |
| 700 | 1 | |a Martinez de Tejada, B |e investigator |4 oth | |
| 700 | 1 | |a Marzolini, C |e investigator |4 oth | |
| 700 | 1 | |a Metzner, K J |e investigator |4 oth | |
| 700 | 1 | |a Müller, N |e investigator |4 oth | |
| 700 | 1 | |a Nemeth, J |e investigator |4 oth | |
| 700 | 1 | |a Nicca, D |e investigator |4 oth | |
| 700 | 1 | |a Paioni, P |e investigator |4 oth | |
| 700 | 1 | |a Pantaleo, G |e investigator |4 oth | |
| 700 | 1 | |a Perreau, M |e investigator |4 oth | |
| 700 | 1 | |a Rauch, A |e investigator |4 oth | |
| 700 | 1 | |a Schmid, P |e investigator |4 oth | |
| 700 | 1 | |a Speck, R |e investigator |4 oth | |
| 700 | 1 | |a Stöckle, M |e investigator |4 oth | |
| 700 | 1 | |a Tarr, P |e investigator |4 oth | |
| 700 | 1 | |a Trkola, A |e investigator |4 oth | |
| 700 | 1 | |a Wandeler, G |e investigator |4 oth | |
| 700 | 1 | |a Yerly, S |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 76(2023), 4 vom: 18. Feb., Seite 730-733 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2023 |g number:4 |g day:18 |g month:02 |g pages:730-733 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciac823 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2023 |e 4 |b 18 |c 02 |h 730-733 | ||